Literature DB >> 2924270

Angioimmunoblastic lymphadenopathy. Review of 44 patients with emphasis on prognostic behavior.

K Aozasa1, M Ohsawa, M Q Fujita, Y Kanayama, N Tominaga, T Yonezawa, T Matsubuchi, M Hirata, H Uda, A Kanamaru.   

Abstract

In order to investigate the relationship between histologic findings and clinical behavior in angioimmunoblastic lymphadenopathy (AILD), 44 patients with AILD were reviewed. These patients comprised 24 men and 20 women with age range from 25 to 84 years of age (median, 64 years). Lymphadenopathy was observed in all patients, systemic in 37, and localized in seven. Polyclonal hypergammaglobulinemia was present in 64% of patients. Histologically clear cells or convoluted cells were observed in 36% and 48% of the patients, respectively. Univariate analysis (log-rank test) for prognostic factors revealed age, appetite, presence of clear cells, or convoluted cells were important factors. However, multivariate analysis revealed that there were no independent factors for prognosis. The presence of clear cells and/or convoluted cells were histologic signs for poor prognosis; autopsy showed that patients with the clear cells with or without convoluted cells mostly died of active disease of AILD with two cases progressing to non-Hodgkin's lymphomas and those with convoluted cells alone died of lung infection. From these findings, AILD could be divided into three groups: AILD with (1) clear cells with or without convoluted cells, (2) convoluted cells alone, or (3) neither cells. The first two groups showed poor prognosis, and the last a favorable prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2924270     DOI: 10.1002/1097-0142(19890415)63:8<1625::aid-cncr2820630832>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

2.  Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

Authors:  J Lorenzen; G Li; M Zhao-Höhn; C Wintzer; R Fischer; M L Hansmann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

4.  Skin lesions and neutrophilic leukemoid reaction in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of the literature.

Authors:  Jianming He; Houjie Liang
Journal:  Clin Case Rep       Date:  2015-04-29

5.  No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.

Authors:  Bei Xu; Peng Liu
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.